跳至主要内容
临床试验/NCT05149118
NCT05149118已完成4 期

Early Postoperative Injections of Polydeoxyribonucleotide Prevents Hypertrophic Scarring After Thyroidectomy: A Randomized Controlled Trial

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2019年2月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
22
试验地点
1
主要终点
modified Vancouver Scar Scale (0 normal skin~15 worst) at the 3-month follow-up

研究概览

简要总结

The investigators aimed to evaluate the efficacy of PDRN administration in early wound healing phase on prevention of post-operative scars after open thyroidectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants who underwent open thyroidectomy between February 2019 and March 2021 at the Thyroid Cancer Center, Department of otorhinolaryngology, Seoul National University Bundang Hospital

排除标准

  • •age younger than 20 years or older than 60 years
  • •history of keloid development
  • •requirement for modified radical neck dissection
  • •previous neck surgery
  • •current pregnancy or breast feeding
  • •allergy to PDRN
  • •taking medications that may affect inflammation and would healing such as isotretinoin, anti-cancer drugs, high dose corticosteroids, and anticoagulants
  • •uncontrolled medical diseases

研究组 & 干预措施

PDRN injected group

Experimental

The participants in treatment group had received two consecutive injections of PDRN one day and two days after the surgery. A total 1mL of PDRN was injected along the suture line at distance of 1cm in each session.

干预措施: Polydeoxyribonucleotide (PDRN) (Procedure)

Control group

No Intervention

The participants in control group were left untreated.

结局指标

主要结局

modified Vancouver Scar Scale (0 normal skin~15 worst) at the 3-month follow-up

时间窗: at 3 months

modified Vancouver Scar Scale (0 normal skin\~15 worst)

次要结局

  • Subjective symptoms at the 3-month follow-up(at 3 months)
  • Erythema and pigmentation at the 3-month follow-up(at 3 months)
  • Scar Height (mm) at the 3-month follow-up(at 3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jung-Won Shin

Associate Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验